Literature DB >> 4020543

Herpes simplex virus encephalitis during childhood: importance of brain biopsy diagnosis.

S Kohl, A R James.   

Abstract

Twelve consecutive pediatric patients 1 day to 11 years of age with suspected herpes simplex virus (HSV) encephalitis underwent brain biopsy. Five were proved to have HSV encephalitis; seven had subdural empyema, malignant glioma, enteroviral encephalitis, (one each), and presumed viral encephalitis, non-HSV (four). Neither epidemiologic, clinical, nor noninvasive laboratory tests were able to help differentiate the two groups of patients. The EEG was more sensitive than the CT scan in demonstrating focal lesions in early HSV encephalitis. In patients with HSV encephalitis, the mean time from hospital admission to appropriate antiviral chemotherapy was 3 days, and the outcome of HSV encephalitis was uniformly poor. In patients with febrile encephalitis-like syndromes with CSF pleocytosis, focal neurologic signs, or other localizing test results (EEG, CT), anticipatory antiviral chemotherapy and brain biopsy are the only hope to prevent the poor outcome associated with HSV encephalitis, to exclude other treatable conditions, and to avoid multiple types of unnecessary empiric therapies.

Entities:  

Mesh:

Year:  1985        PMID: 4020543     DOI: 10.1016/s0022-3476(85)80127-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

1.  Brain biopsy in the management of focal encephalitis.

Authors:  N E Anderson; E W Willoughby; B J Synek; M C Croxson; G L Glasgow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

2.  A polymerase chain reaction assay of cerebrospinal fluid in patients with suspected herpes simplex encephalitis.

Authors:  N E Anderson; K F Powell; M C Croxson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

3.  Intracranial pressure in childhood central nervous system infections.

Authors:  P Rebaud; J C Berthier; E Hartemann; D Floret
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.